TY - JOUR
T1 - Astrocyte dysfunction and neurovascular impairment in neurological disorders
T2 - Correlation or causation?
AU - McConnell, Heather L.
AU - Li, Zhenzhou
AU - Woltjer, Randall L.
AU - Mishra, Anusha
N1 - Funding Information:
Funding: This work was supported by a National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award T32 [ T32HL094294 ] to H.M.; a Western Light Talent Training Fellowship to Z.L.; NIH NIA Grants [ R01AG056712 and P30AG008017 ] to R.W.; a Collins Medical Trust grant to A.M.; and NIH NINDS [ P30NS061800 ] (PI: Aicher), which supports the OHSU Advanced Light Microscopy Core.
Publisher Copyright:
© 2019
PY - 2019/9
Y1 - 2019/9
N2 - The neurovascular unit, consisting of neurons, astrocytes, and vascular cells, has become the focus of much discussion in the last two decades and emerging literature now suggests an association between neurovascular dysfunction and neurological disorders. In this review, we synthesize the known and suspected contributions of astrocytes to neurovascular dysfunction in disease. Throughout the brain, astrocytes are centrally positioned to dynamically mediate interactions between neurons and the cerebral vasculature, and play key roles in blood-brain barrier maintenance and neurovascular coupling. It is increasingly apparent that the changes in astrocytes in response to a variety of insults to brain tissue –collectively referred to as “reactive astrogliosis” – are not just an epiphenomenon restricted to morphological alterations, but comprise functional changes in astrocytes that contribute to the phenotype of neurological diseases with both beneficial and detrimental effects. In the context of the neurovascular unit, astrocyte dysfunction accompanies, and may contribute to, blood-brain barrier impairment and neurovascular dysregulation, highlighting the need to determine the exact nature of the relationship between astrocyte dysfunction and neurovascular impairments. Targeting astrocytes may represent a new strategy in combinatorial therapeutics for preventing the mismatch of energy supply and demand that often accompanies neurological disorders.
AB - The neurovascular unit, consisting of neurons, astrocytes, and vascular cells, has become the focus of much discussion in the last two decades and emerging literature now suggests an association between neurovascular dysfunction and neurological disorders. In this review, we synthesize the known and suspected contributions of astrocytes to neurovascular dysfunction in disease. Throughout the brain, astrocytes are centrally positioned to dynamically mediate interactions between neurons and the cerebral vasculature, and play key roles in blood-brain barrier maintenance and neurovascular coupling. It is increasingly apparent that the changes in astrocytes in response to a variety of insults to brain tissue –collectively referred to as “reactive astrogliosis” – are not just an epiphenomenon restricted to morphological alterations, but comprise functional changes in astrocytes that contribute to the phenotype of neurological diseases with both beneficial and detrimental effects. In the context of the neurovascular unit, astrocyte dysfunction accompanies, and may contribute to, blood-brain barrier impairment and neurovascular dysregulation, highlighting the need to determine the exact nature of the relationship between astrocyte dysfunction and neurovascular impairments. Targeting astrocytes may represent a new strategy in combinatorial therapeutics for preventing the mismatch of energy supply and demand that often accompanies neurological disorders.
KW - Astrocytes
KW - Astrogliosis
KW - Blood-brain barrier
KW - Neurodegeneration
KW - Neurovascular coupling
KW - Neurovascular unit
UR - http://www.scopus.com/inward/record.url?scp=85067936937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067936937&partnerID=8YFLogxK
U2 - 10.1016/j.neuint.2019.04.005
DO - 10.1016/j.neuint.2019.04.005
M3 - Review article
C2 - 30986503
AN - SCOPUS:85067936937
SN - 0197-0186
VL - 128
SP - 70
EP - 84
JO - Neurochemistry International
JF - Neurochemistry International
ER -